Ezio Bonvini

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Robbie G. Majzner, Johanna Theruvath, Anandani Nellan et al. · Clinical Cancer Research · 2019 · 672 citations · Full text

Medicine, Immunology, Oncology +15

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet · 2011 · 489 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Hope S. Rugo, Seock‐Ah Im, Fátima Cardoso et al. · JAMA Oncology · 2021 · 349 citations · Full text

Medicine, Oncology, Pharmacology +17

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster et al. · Blood · 2020 · 322 citations · Full text

Medicine, Hematology, Oncology +13

Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

Deryk Loo, Ralph Alderson, Francine Z. Chen et al. · Clinical Cancer Research · 2012 · 280 citations

Pharmacy, Immunology, Oncology +17